|
Novartis Drug for Smoker’s Cough Boosts Lung Function in Study
Novartis’s experimental drug for smoker’s cough helped patients in a late-stage trial, and was at least as good as a treatment sold by Boehringer Ingelheim and Pfizer.
Businessweek |
Register Now
Archives